Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers

Not Applicable

Completed

• Conditions: Lipolysis
• Interventions: Other: Resveratrol lipoic Acid; Other: Placebo

• Registration Number: NCT03062163
• Lead Sponsor: Chulalongkorn University

Brief Summary

To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers

Detailed Description

66 participants with overweight received a resveratrol and lipoic acid transdermal patch treatment. The treatment areas have been treated including left and right arms. Subjects were evaluated using standardized measurements of body weight and circumference of arms at baseline and 2 weeks follow-up visits. Evaluation of physician were also measured.

Study Timeline

• Study Start: 2017-01-23
• Status Verified: 2017-02
• Primary Completion: 2017-02-06
• Study Completion: 2017-02-06
• Study First Submitted: 2017-02-13
• Study First Submitted QC: 2017-02-20
• Last Update Submitted: 2017-02-20
• Study First Posted: 2017-02-23
• Last Update Posted: 2017-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

• healthy volunteers with BMI > 23

Exclusion Criteria

• resveratrol or lipoic acid allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Resveratrol lipoic Acid	Resveratrol lipoic Acid	lipoic and resveratrol was loaded on the patch
Placebo	Placebo	normal saline was loaded on transdermal patch

Primary Outcome Measures

Name	Time	Method
fat thickness measured	2 weeks	fat thickness measurement by ultrasound

Trial Locations

Locations (1)

Faculty of Medicine, Chulalongkorn University; 🇹🇭 Bangkok, Thailand